FDA
approval
· 2022-05-27
FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
Summary
FDA approved a supplemental application for Enalapril Maleate and Hydrochlorothiazide (a fixed-dose combination) by Taro Pharmaceuticals U.S.A., Inc., enabling …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE)